Novel Diagnostics // Put your Diabetic foot ulcer patients back on their feet sooner
Fri, Jul 31, 2020 · 6:00 PM
ABOUT THIS WEBINAR
The first lecture will review point-of-care biomarker testing and fluorescence imaging as part of an outpatient antibiotic stewardship program. Clinical signs and symptoms may not reveal the reasons chronic wounds fail to heal. A review of recent literature reveals that CSS is inaccurate in determining clinically significant bacterial load in chronic wounds. Swab cultures suffer from the same unreliability. Tissue cultures and molecular testing are more accurate, but the reports take days to return to the clinician. By this time the patient has left the clinic without needed antimicrobial therapy or on unnecessary antibiotics.
In the second lecture Professor Lazaro and Dr Ahluwalia will present the International guidelines and their recommendations for the prevention and management of DFUs. In order to reduce healing time and to initiate the treatment the sooner, making the right diagnosis and implanting the best standard of care are key component to efficient DFUs management.
Diabetic foot ulcers (DFUs) represent a high burden for patients, Health Care Professionals and health authorities. Therefore, wound dressing is of significant importance to promote the wound healing process. TLC-NOSF technology has proven its efficacy to reduce healing time of DFUs and is the first and only dressing recommended by International guidelines.
A fast-track pathway (FTP) DFUs was developed to allow a clear identification of DFU’s severity, specific management and appropriate and timely referral to a specialized setting.
This FTP was adapted to the Covid-19 situation in order to adapt the DFUs management according to alert signs.
Director, Institute of Skin Integrity and Infection Prevention, University of Huddersfield
Karen is Professor of Skin Integrity and Director for the Institute of Skin Integrity and Infection Prevention. She is also Visiting Professor in the School of Nursing, Faculty of Health at the Queensland University of Technology, Australia and...
Dr. Thomas E. Serena MD FACS FACHM MAPWCA, Founder and Medical Director of The SerenaGroup®, a family of wound, hyperbaric and research companies, completed his residency in Surgery at Penn State University and maintains board certification in...
Tenured Professor & Clinical Director of the Diabetic Foot Research Group, Complutense University and Health Research Institute at San Carlos Teaching Hospital, Madrid, Spain
Dr. Jose Luis Lázaro-Martínez is a full-time Professor at the University of the Complutense University of Madrid (UCM). He got his PhD degree at the same university doing his doctoral thesis on biomechanics of the diabetic foot. He is an expert in...